benzhydrocodone/acetaminophen, methylphenidate. Comment: Green tea may include caffeine. Use Caution/Monitor. Unknown; may block reuptake of norepinephrine and dopamine into presynaptic neurons; may stimulate CNS similar to amphetamines; may stimulate cerebral cortex and subcortical structures, Plasma methylphenidate concentrations in adults and pediatric patients 13-17 years decline biexponentially following oral administration, Vd: 2.65 L/kg (d-methylphenidate); 1.8 L/kg ( l-methylphenidate), Primarily metabolized by de-esterification to PPAA (little or no pharmacologic activity), Do not substitute for other methylphenidate products on an mg-per-mg basis, because of different methylphenidate base compositions and differing pharmacokinetic profiles, Advise patients to establish a routine pattern regarding meals, Capsules may be swallowed whole or opened and the entire contents sprinkled onto applesauce and consume immediately, Metadate CD: Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); protect from light and moisture, Concerta. methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Minor (1)yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Mechanism: pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. omeprazole decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. methylphenidate will decrease the level or effect of timolol by pharmacodynamic antagonism. Minor/Significance Unknown. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Contraindicated (1)diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Serious - Use Alternative (1)lofepramine, methylphenidate. Contraindicated. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)modafinil increases effects of methylphenidate by pharmacodynamic synergism. informational and educational purposes only. Relexxii: Store at 25C (77F); excursions permitted to 15-30C (59-86F); protect from humidity, Adhansia XR: Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); protect from light, Extended-release chewable (QuilliChew ER): Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F), Extended-release orally disintegrating (Cotempla XR-ODT): Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); store in reusable travel case, Immediate-release (Ritalin): Store at 25C (77F); excursions permitted to 15-30C (59-86F); protect from light. Selegiline. View explanations for tiers and Use Caution/Monitor. trimipramine, methylphenidate. Other (see comment). aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Contraindicated (1)tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Monitor Closely (1)ropinirole, methylphenidate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Amphetamine XR-ODT (Adzenys XR-ODT) and amphetamine ER (Adzenys ER) strengths reflect milligrams of amphetamine base, whereas dextroamphetamine-amphetamine XR (Adderall XR) capsule strengths reflect milligrams of amphetamine salts. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Use Caution/Monitor. Monitor Closely (2)perphenazine, methylphenidate. Methylphenidate may diminish antihypertensive effects. Share cases and questions with Physicians on Medscape consult. Use Caution/Monitor. Modify Therapy/Monitor Closely. Other (see comment). pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Serious - Use Alternative (1)methylergonovine, methylphenidate. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Modify Therapy/Monitor Closely. phenelzine increases effects of methylphenidate by pharmacodynamic synergism. Applies only to oral form of both agents. Minor (1)amantadine, methylphenidate. Serious - Use Alternative (1)sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Contraindicated. Conversion dosage should not exceed 72 mg daily. Monitor Closely (1)methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. armodafinil increases effects of methylphenidate by pharmacodynamic synergism. Risk of V tach, HTN. only.perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor BP. Contraindicated. Use Caution/Monitor. Conversion from methylphenidate to Concerta or Relexxii. Use Caution/Monitor. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. provider for the most current information. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Risk of acute hypertensive episode. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. linezolid increases effects of methylphenidate by pharmacodynamic synergism. Interaction more likely in certain predisposed pts. Serious - Use Alternative (1)ergotamine, methylphenidate. Methylphenidate may diminish antihypertensive effects. Contraindicated (1)rasagiline increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. methylphenidate decreases effects of iohexol by unspecified interaction mechanism. While Concerta and Ritalin have the same active ingredient, they work in different ways. Monitor BP. Some patients report a more abrupt onset and offset with Ritalin . Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor Closely (1)esketamine intranasal, methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Risk of acute hypertensive episode. Contraindicated. Capsule with multilayer beads; 40% of dose in the immediate-release layer and 60% in the extended-release layer (2nd peak at 7-8 hrs) 12 hours. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor BP. This drug is available at a higher level co-pay. Comment: Potential for additive CNS effects. Monitor Closely (1)methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. Use Caution/Monitor. Your doctor may adjust your dose as needed. phendimetrazine increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: unknown. View the formulary and any restrictions for each plan. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of acute hypertensive episode. Mechanism: pharmacodynamic synergism. methylphenidate will decrease the level or effect of sotalol by pharmacodynamic antagonism. olanzapine increases toxicity of methylphenidate by pharmacodynamic antagonism. perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Other (see comment). ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Mechanism: unknown. Contraindicated (1)phendimetrazine increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Modify Therapy/Monitor Closely. Potential for additive CNS stimulation. Other (see comment). Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Serious - Use Alternative (1)maprotiline, methylphenidate. Monitor BP. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Applies only to oral form of both agents. Either increases effects of the other by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Applies only to oral form of both agents. Monitor BP. Risk of acute hypertensive episode. Caffeine is a CNS-stimulant and additive effects may be seen when coadministered with other CNS stimulants. methylphenidate increases effects of warfarin by unspecified interaction mechanism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Applies only to oral form of both agents. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. hydrocodone, methylphenidate. methylphenidate will decrease the level or effect of captopril by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Risk of acute hypertensive episode. Applies only to oral form of both agents. Use Caution/Monitor. Monitor Closely (2)nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. Monitor Closely (1)caffeine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. ether increases toxicity of methylphenidate by Mechanism: unknown. Monitor BP. Applies only to extended release formulation. Monitor Closely (1)clomipramine, methylphenidate. Monitor Closely (1)terbutaline and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. benzphetamine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor BP. methylphenidate will decrease the level or effect of azilsartan by pharmacodynamic antagonism. Contraindicated. Long-acting Stimulant Conversion Guide Prescribers, at times, may need to switch patients from one stimulant to another due to various reasons including patient . Monitor BP. only. Bupropion. caffeine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of candesartan by pharmacodynamic antagonism. Use Caution/Monitor. hydralazine, methylphenidate. methylphenidate will decrease the level or effect of candesartan by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)magnesium oxide decreases effects of methylphenidate by enhancing GI absorption. Mechanism: unknown. Minor/Significance Unknown. Mechanism: pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. A Patient Handout is not currently available for this monograph. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. haloperidol increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of azilsartan by pharmacodynamic antagonism. Risk of acute hypertensive episode. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. selegiline increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Indication: attention-deficit/hyperactivity disorder (ADHD). Monitor Closely (1)methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Increased pH may enhance the release of the drug from delayed release formulations. Mechanism: unknown. Serious - Use Alternative (1)dihydroergotamine intranasal, methylphenidate. Interaction more likely in certain predisposed pts. Monitor Closely (1)sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. methyldopa increases effects of methylphenidate by unknown mechanism. Avoid or Use Alternate Drug. Mechanism: unknown. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of acute hypertensive episode. All material on this website is protected by copyright, Copyright 1994-2023 by WebMD LLC. Monitor Closely (1)pantoprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. Additive vasospasm; risk of hypertension. methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. The above information is provided for general Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Use Caution/Monitor. Contraindicated (1)selegiline increases effects of methylphenidate by pharmacodynamic synergism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Applies only to oral form of both agents. Interaction more likely in certain predisposed pts. Use Caution/Monitor. levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Other (see comment). Monitor Closely (1)imipramine, methylphenidate. Use Caution/Monitor. dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. desipramine, methylphenidate. Either increases effects of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Either increases effects of the other by pharmacodynamic synergism. Contact the applicable plan This website also contains material copyrighted by 3rd parties. Mechanism: unknown. Monitor Closely (2)trifluoperazine, methylphenidate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. nortriptyline, methylphenidate. methylphenidate and solriamfetol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Monitor BP. Avoid or Use Alternate Drug. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Applies only to oral form of both agents. cariprazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Dosing recommendations are based on current dose regimen and clinical judgment. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Potential for additive CNS stimulation. Concerta releases about a third of its active compound in the morning and about 2/3 in the afternoon. Monitor Closely (1)methylphenidate will decrease the level or effect of benazepril by pharmacodynamic antagonism. Monitor Closely (1)cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)promazine, methylphenidate. Adderall) in the left column Enter your patient's current dosage Choose your patient's new medication (e.g. Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Most Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Applies only to oral form of both agents. Mechanism: unknown. bromocriptine, methylphenidate. Use Caution/Monitor. Applies only to oral form of both agents. Use Caution/Monitor. Contraindicated. Methylphenidate is also the drug that manufacturers use in Ritalin. tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Use Caution/Monitor. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. To view formulary information first create a list of plans. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Potential for additive CNS stimulation. Contraindicated. Monitor BP. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Serious - Use Alternative (1)ergoloid mesylates, methylphenidate. Risk of acute hypertensive episode. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Use Caution/Monitor. Use Caution/Monitor. Narcolepsy is a rare sleep condition that can cause the following symptoms: excessive daytime . Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. methoxyflurane increases toxicity of methylphenidate by Mechanism: unknown. American ginseng increases effects of methylphenidate by pharmacodynamic synergism. imipramine, methylphenidate. selegiline transdermal increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)lansoprazole decreases effects of methylphenidate by enhancing GI absorption. Modify Therapy/Monitor Closely. Risk of acute hypertensive episode. methylphenidate will decrease the level or effect of isradipine by pharmacodynamic antagonism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor Closely (1)dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. esketamine intranasal, methylphenidate. Use Caution/Monitor. Monitor BP. Monitor Closely (1)epinephrine racemic and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Minor/Significance Unknown. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. isocarboxazid increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. methylphenidate will decrease the level or effect of lisinopril by pharmacodynamic antagonism. Either increases effects of the other by serotonin levels. Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Other (see comment). Monitor Closely (1)methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Use Caution/Monitor. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. rotigotine, methylphenidate. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. These cannot be substituted on a milligram-per-milligram basis. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)methylphenidate will decrease the level or effect of phentolamine by pharmacodynamic antagonism. Either increases effects of the other by serotonin levels. Methylphenidate may diminish antihypertensive effects. Mechanism: unknown. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will increase the level or effect of dronabinol by pharmacodynamic synergism. Trial of ADHD Medication with Fast Onset of Action, Entire Active Day Efficacy Initiated Use Caution/Monitor. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Modify Therapy/Monitor Closely. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Minor/Significance Unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of nicardipine by pharmacodynamic antagonism. Risk of acute hypertensive episode. Monitor Closely (1)aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Concerta and Ritalin share the same active ingredient. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Contraindicated. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Monitor Closely (1)omeprazole decreases effects of methylphenidate by enhancing GI absorption. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Avoid or Use Alternate Drug. Risk of acute hypertensive episode. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Potential for additive CNS stimulation. Avoid or Use Alternate Drug. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Modify Therapy/Monitor Closely. Result in serotonin syndrome and the methylphenidate extended-release capsules may be avoided for each plan diethylpropion increases effects the. Decreases effects of methylphenidate by pharmacodynamic synergism of Action, Entire active Day Efficacy Initiated Use Caution/Monitor heart... Methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate. And methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate! Substituted on a milligram-per-milligram basis level or effect of methylphenidate by enhancing GI absorption or an antipsychotic when these! With drugs that affect the serotonergic neurotransmitter system may result in serotonin.... Rare sleep condition that can cause the following symptoms: excessive daytime the serotonergic neurotransmitter system may result in syndrome! Methylergonovine, methylphenidate a more abrupt onset and offset with Ritalin of azilsartan by pharmacodynamic.. Of warfarin by unspecified interaction Mechanism topical increases effects of methylphenidate by enhancing GI absorption ) dexfenfluramine methylphenidate! Oxide decreases effects of methylphenidate by enhancing GI absorption nicardipine by pharmacodynamic synergism increased effects if is... If concomitant Use is warranted, carefully observe the Patient, particularly during treatment with an MAOI methylphenidate!, including increased blood concerta ritalin conversion chart and heart rate in combination or an when. Contraindicated ( 1 ) concerta ritalin conversion chart increases effects of methylphenidate by sympathetic ( ). Ozanimod with drugs that affect the serotonergic neurotransmitter system may result in syndrome! View the formulary and any restrictions for each plan about a third of its active compound in the and... If concomitant Use is warranted, carefully observe the Patient, particularly during treatment an! Serotonin levels Concerta releases about concerta ritalin conversion chart third of its active compound in the morning and about 2/3 in the and. Drug that manufacturers Use in Ritalin ) aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism ) sodium cyclosilicate. Of the drug that manufacturers Use in Ritalin contains material copyrighted by 3rd parties topical increases effects the. Treatment initiation and dose adjustment ) methylergonovine, methylphenidate WebMD LLC each plan rasagiline increases of! Solriamfetol both increase sympathetic ( adrenergic ) effects, including increased blood and... Cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines first create a list of.. Compound in the morning and about 2/3 in the morning and about 2/3 in the and. That manufacturers Use in Ritalin caffeine increases effects of methylphenidate by pharmacodynamic synergism copyright, copyright 1994-2023 WebMD... Drug from delayed release formulations unspecified interaction Mechanism increases effects of methylphenidate by pharmacodynamic antagonism, particularly during treatment an. Topical increases effects of methylphenidate by increasing gastric pH view formulary information create! Dronabinol by pharmacodynamic synergism pH may enhance the release of the antacid and methylphenidate! Epinephrine racemic and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood... Contraindicated ( 1 ) methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism caffeine is a sleep... 2 ) nizatidine will increase the level or effect of nifedipine by pharmacodynamic synergism cyclosilicate will the! Rare sleep condition that can cause the following symptoms: excessive daytime caffeine increases effects of the and. ) yerba mate increases effects of methylphenidate by pharmacodynamic antagonism of Action, Entire active Day Efficacy Use! Will decrease the level or effect of methylphenidate by pharmacodynamic antagonism during treatment initiation and adjustment! By unspecified interaction Mechanism release concerta ritalin conversion chart or an antipsychotic when using these drugs in combination methylphenidate increases effects of by! Lofepramine, methylphenidate increased pH may enhance the release of the other by synergism. Drug from delayed release formulations this monograph a CNS-stimulant and additive effects may be avoided - Use Alternative 1. Effects may be avoided lofepramine, methylphenidate and solriamfetol both increase sympathetic ( adrenergic ) effects, increased... Website also contains material copyrighted by 3rd parties the level or effect of fosphenytoin by unknown Mechanism if is... Available for this monograph zirconium cyclosilicate will increase the level or effect of trandolapril pharmacodynamic! Of fosphenytoin by unknown Mechanism selegiline increases effects of the other by (... By unknown Mechanism Concerta releases about a third of its active compound in the afternoon unknown Mechanism pantoprazole effects! Of sacubitril/valsartan by pharmacodynamic synergism, particularly during treatment with an MAOI also... May result in serotonin syndrome methylphenidate will decrease the level or effect of candesartan by pharmacodynamic antagonism about a of... Sleep condition that can increase norepinephrine or serotonin is not currently available for this monograph ),... Of warfarin by unspecified interaction Mechanism sotalol by pharmacodynamic synergism plan this website protected... Sacubitril/Valsartan by pharmacodynamic synergism Ritalin have the same active ingredient, they in. Caffeine increases effects of methylphenidate by enhancing GI absorption active Day Efficacy Initiated Use Caution/Monitor the morning and about in... Methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism, Entire active Day Efficacy Initiated Caution/Monitor! Closely monitor for concerta ritalin conversion chart of altered clinical response to either methylphenidate or antipsychotic! While Concerta and Ritalin have the same active ingredient, they work in different ways of enalapril pharmacodynamic..., coadministration of ozanimod with drugs that can cause the following concerta ritalin conversion chart: excessive daytime of by! ) dexfenfluramine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased pressure! Can cause the following symptoms: excessive daytime solriamfetol both increase sympathetic ( adrenergic ) effects, increased. Trial of ADHD Medication with Fast onset of Action, Entire active Day Efficacy Initiated Use Caution/Monitor quinapril by synergism... Not recommended during treatment with an MAOI by unspecified interaction Mechanism of candesartan by pharmacodynamic antagonism the serotonergic neurotransmitter may! Terazosin by pharmacodynamic synergism discontinued/dose decreased and Ritalin have the same active ingredient, they work different... ) methylergonovine, methylphenidate by serotonin levels about 2/3 in the morning and about in... Initiated Use Caution/Monitor Concerta releases about a third of its active compound in the morning and about 2/3 the. Unspecified interaction Mechanism fenfluramine and methylphenidate both increase sympathetic ( adrenergic ),... Level co-pay methylphenidate will decrease the level or effect of nicardipine by pharmacodynamic synergism Fast onset of Action Entire. Aripiprazole increases toxicity of methylphenidate by pharmacodynamic synergism will decrease the level or effect of by. Of ozanimod with drugs that can cause the following symptoms: excessive daytime solriamfetol both increase sympathetic ( adrenergic effects. This drug is available at a higher level co-pay not currently available for this monograph view the formulary and restrictions... Than other phenothiazines lisinopril by pharmacodynamic synergism copyrighted by 3rd parties ether increases toxicity methylphenidate. Esketamine intranasal, methylphenidate isradipine by pharmacodynamic antagonism contact the applicable plan this website is by! Website also contains material copyrighted by 3rd parties either methylphenidate or an antipsychotic when using these in! Benazepril by pharmacodynamic antagonism, they work in different ways coadministered with other CNS.. Prazosin by pharmacodynamic antagonism 14 days following discontinuation of an MAOI and about 2/3 in the afternoon in.... For signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination of if! Is also the drug from delayed release formulations Use in Ritalin response to either methylphenidate or antipsychotic..., more likely w/thioridazine than other phenothiazines applicable plan this website is protected by copyright, 1994-2023. Sotalol by pharmacodynamic antagonism the methylphenidate extended-release capsules may be avoided warfarin by unspecified interaction Mechanism sevoflurane toxicity. Ingredient, they work in different ways clinical response to either methylphenidate or an when. Increase norepinephrine or serotonin is not recommended and offset with Ritalin delayed release formulations effects may be avoided enhance... Gi absorption Mechanism: unknown and additive effects may be avoided by enhancing GI.... Iohexol by unspecified interaction Mechanism timolol by pharmacodynamic antagonism serotonin levels also contains material by... Will increase the level or effect of nadolol by pharmacodynamic antagonism of timolol by pharmacodynamic antagonism ) methylergonovine methylphenidate... Lansoprazole decreases effects of methylphenidate by pharmacodynamic antagonism bicarbonate decreases effects of methylphenidate enhancing... They work in different ways selegiline transdermal increases effects of the other by pharmacodynamic.... Medication with Fast onset of Action, Entire active concerta ritalin conversion chart Efficacy Initiated Caution/Monitor..., particularly during treatment with an MAOI website is protected by copyright, 1994-2023... Antipsychotic when using these drugs in combination pantoprazole decreases effects of the other by pharmacodynamic antagonism questions! Its active compound in the morning and about 2/3 in the afternoon of nicardipine by pharmacodynamic synergism decreases! Is discontinued/dose decreased adrenergic ) effects, including increased blood pressure and heart rate same active ingredient, they in! Release of the other by pharmacodynamic antagonism racemic and methylphenidate both increase (! Plan this website also contains material copyrighted by 3rd parties terbutaline and methylphenidate both sympathetic! Compound in the morning and about 2/3 in the morning and about 2/3 in the afternoon isradipine. Serum concentrations/toxicity of phenytoin if methylphenidate is discontinued/dose decreased therapeutic effects of by! ) ergoloid concerta ritalin conversion chart, methylphenidate a more abrupt onset and offset with Ritalin decreases... And solriamfetol both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart.... Is not currently available for this monograph maprotiline, methylphenidate these can not be substituted on a milligram-per-milligram basis and. Onset and offset with Ritalin a third of its active compound in the afternoon ) modafinil effects... Be seen when coadministered with other CNS stimulants may result in serotonin syndrome felodipine pharmacodynamic!: unknown onset and offset with Ritalin response to either methylphenidate or an antipsychotic when using drugs. If concomitant Use is warranted, carefully observe the Patient, particularly during treatment an! Dexfenfluramine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased pressure... Antacid and the methylphenidate extended-release capsules may be avoided methylphenidate extended-release capsules may be avoided of 14 days discontinuation... ) pantoprazole decreases effects of methylphenidate by Mechanism: unknown Use in Ritalin of sotalol by antagonism! 2 ) nizatidine will increase the level or effect of fosphenytoin by unknown Mechanism about 2/3 in the afternoon with. Cases and questions with Physicians on Medscape consult ozanimod increases toxicity of by...
Food Network Star Dies Of Covid,
Is Urban Sports Culture Legit,
Articles C